These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6301593)

  • 1. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P; Wolkin A
    J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol.
    Karler R; Calder LD; Turkanis SA
    Neuropharmacology; 1986 Apr; 25(4):441-6. PubMed ID: 3012403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.
    Davis WM; Hatoum NS
    Gen Pharmacol; 1983; 14(2):247-52. PubMed ID: 6301931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
    Turkanis SA; Smiley KA; Borys HK; Olsen DM; Karler R
    Epilepsia; 1979 Aug; 20(4):351-63. PubMed ID: 477630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Possible Anticonvulsant Effect of Δ
    Benson MJ; Anderson LL; Low IK; Luo JL; Kevin RC; Zhou C; McGregor IS; Arnold JC
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):46-57. PubMed ID: 33998858
    [No Abstract]   [Full Text] [Related]  

  • 11. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
    Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
    Hiltunen AJ; Järbe TU
    Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal.
    File SE; Wilks LJ
    Psychopharmacology (Berl); 1990; 100(2):237-42. PubMed ID: 2305012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cannabidiol and Δ9-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model.
    Dlugosz L; Zhou HZ; Scott BW; Burnham M
    Epilepsy Res; 2023 Feb; 190():107087. PubMed ID: 36646020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats.
    Jacobs JA; Dellarco AJ; Manfredi RA; Harclerode J
    J Pharm Pharmacol; 1979 May; 31(5):341-2. PubMed ID: 37310
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.